JPS59508B2 - ノウケツカンカクチヨウザイ ２ ３− チカン −４− フクソカンジヨウアミノスルホニルベンゼンスルホンアミド ノ セイホウ - Google Patents

ノウケツカンカクチヨウザイ ２ ３− チカン −４− フクソカンジヨウアミノスルホニルベンゼンスルホンアミド ノ セイホウ

Info

Publication number
JPS59508B2
JPS59508B2 JP48090450A JP9045073A JPS59508B2 JP S59508 B2 JPS59508 B2 JP S59508B2 JP 48090450 A JP48090450 A JP 48090450A JP 9045073 A JP9045073 A JP 9045073A JP S59508 B2 JPS59508 B2 JP S59508B2
Authority
JP
Japan
Prior art keywords
formula
compounds
formulas
compound
blood flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP48090450A
Other languages
English (en)
Japanese (ja)
Other versions
JPS4985066A (enExample
Inventor
エドワード クロス ピーター
ガドスビー ブライアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Original Assignee
Pfizer Corp Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium filed Critical Pfizer Corp Belgium
Publication of JPS4985066A publication Critical patent/JPS4985066A/ja
Publication of JPS59508B2 publication Critical patent/JPS59508B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B31/00—Disazo and polyazo dyes of the type A->B->C, A->B->C->D, or the like, prepared by diazotising and coupling
    • C09B31/02—Disazo dyes
    • C09B31/12—Disazo dyes from other coupling components "C"
    • C09B31/14—Heterocyclic components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP48090450A 1972-08-12 1973-08-11 ノウケツカンカクチヨウザイ ２ ３− チカン −４− フクソカンジヨウアミノスルホニルベンゼンスルホンアミド ノ セイホウ Expired JPS59508B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3772072A GB1380009A (en) 1972-08-12 1972-08-12 Cyclic derivatives of 1,4-benzene disulphonamide

Publications (2)

Publication Number Publication Date
JPS4985066A JPS4985066A (enExample) 1974-08-15
JPS59508B2 true JPS59508B2 (ja) 1984-01-07

Family

ID=10398552

Family Applications (2)

Application Number Title Priority Date Filing Date
JP48090450A Expired JPS59508B2 (ja) 1972-08-12 1973-08-11 ノウケツカンカクチヨウザイ ２ ３− チカン −４− フクソカンジヨウアミノスルホニルベンゼンスルホンアミド ノ セイホウ
JP56116291A Expired JPS5857431B2 (ja) 1972-08-12 1981-07-24 脳血管拡張剤２，３−置換−４−複素環状アミノスルホニルベンゼンスルホンアミドの製法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP56116291A Expired JPS5857431B2 (ja) 1972-08-12 1981-07-24 脳血管拡張剤２，３−置換−４−複素環状アミノスルホニルベンゼンスルホンアミドの製法

Country Status (16)

Country Link
US (1) US3867390A (enExample)
JP (2) JPS59508B2 (enExample)
AT (1) AT331248B (enExample)
AU (1) AU5908473A (enExample)
BE (1) BE803373A (enExample)
CA (1) CA978945A (enExample)
DE (1) DE2340010A1 (enExample)
ES (1) ES417806A1 (enExample)
FR (1) FR2195449B1 (enExample)
GB (1) GB1380009A (enExample)
IE (1) IE38177B1 (enExample)
IN (1) IN139006B (enExample)
LU (1) LU68211A1 (enExample)
NL (1) NL162641C (enExample)
SE (1) SE385008B (enExample)
ZA (1) ZA735474B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070361A (en) * 1977-04-21 1978-01-24 E. R. Squibb & Sons, Inc. Mercaptoalkylsulfonyl proline and pipecolic acid and esters thereof
DE2720654A1 (de) * 1977-05-07 1978-11-16 Bayer Ag Azolyl-alkancarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS5922023A (ja) * 1982-07-27 1984-02-04 Hoya Corp ビ−ムスプリツタ−

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165550A (en) * 1960-06-29 1965-01-12 Pfizer & Co C N-substituted p-benzenedisulfonamides

Also Published As

Publication number Publication date
US3867390A (en) 1975-02-18
AT331248B (de) 1976-08-10
IE38177L (en) 1974-02-12
JPS4985066A (enExample) 1974-08-15
JPS5857431B2 (ja) 1983-12-20
NL162641B (nl) 1980-01-15
IE38177B1 (en) 1978-01-18
LU68211A1 (enExample) 1975-05-21
CA978945A (en) 1975-12-02
GB1380009A (en) 1975-01-08
NL7311000A (enExample) 1974-02-14
IN139006B (enExample) 1976-04-24
SE385008B (sv) 1976-05-31
BE803373A (fr) 1974-02-08
ATA691573A (de) 1975-11-15
AU5908473A (en) 1975-02-13
FR2195449B1 (enExample) 1977-09-09
ZA735474B (en) 1974-08-28
FR2195449A1 (enExample) 1974-03-08
DE2340010A1 (de) 1974-03-14
JPS57131774A (en) 1982-08-14
ES417806A1 (es) 1976-03-01
NL162641C (nl) 1980-06-16

Similar Documents

Publication Publication Date Title
EP0623612B1 (en) Terazosin polymorph and pharmaceutical composition
US5739167A (en) Desferrioxamine-B salts and their use as orally effective iron chelators
JPH05163148A (ja) 抗腫瘍剤
JPS59508B2 (ja) ノウケツカンカクチヨウザイ ２ ３− チカン −４− フクソカンジヨウアミノスルホニルベンゼンスルホンアミド ノ セイホウ
US3764700A (en) Treatment of the circulatory system with the lithium salt of hydroquinone sulfonic acid
JPS62207212A (ja) 抗アレルギ−剤
JP2025011312A (ja) ｐ－ボロノフェニルアラニンを含有する注射液剤の析出防止方法
JPS6230994B2 (enExample)
JPH0656669A (ja) 活性酸素消去作用を持つプテリン誘導体製剤
JPS639493B2 (enExample)
JPS604189B2 (ja) 抗菌剤およびその製法
JPH0737383B2 (ja) 胃酸分泌抑制剤含有固型製剤
US3459854A (en) Tetracycline cyclohexyl sulphamate and process for preparation
JP4130700B2 (ja) 抗腫瘍剤含有組成物
CN111072755A (zh) 力肽络合物、其药物组合物、其制备方法和应用
KR100809778B1 (ko) 새로운 2-(알파-엔-펜타노일)벤조에이트들과, 그들의제조와 사용
JP7770572B2 (ja) 虚血性脳損傷を予防または治療するための医薬の調製におけるアイルデナフィルまたはその塩の使用
DE68912159T2 (de) Dioxoquinazolinderivat enthaltendes Antihypertensivum.
KR100344099B1 (ko) 신규한비페닐디카르복실산유도체와이의제조방법
JPH0193526A (ja) 白血球減少の回復剤
JPH11130672A (ja) 脂質過酸化抑制剤
EP0334369B1 (en) Antiarteriosclerotic agent
JPH0368578A (ja) ビスベンジルイソキノリン誘導体
JPH0260648B2 (enExample)
EP0319986A2 (en) Fibrinolytic agents

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370